Treace Medical Concepts I... (TMCI)
| Bid | 6.56 |
| Market Cap | 524.43M |
| Revenue (ttm) | 210.29M |
| Net Income (ttm) | -55.99M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -9.31 |
| Forward PE | -13.53 |
| Analyst | Hold |
| Ask | 9.88 |
| Volume | 177,434 |
| Avg. Volume (20D) | 411,245 |
| Open | 8.62 |
| Previous Close | 8.58 |
| Day's Range | 8.36 - 8.84 |
| 52-Week Range | 3.92 - 13.24 |
| Beta | 0.78 |
About TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers pro...
Analyst Forecast
According to 7 analyst ratings, the average rating for TMCI stock is "Hold." The 12-month stock price forecast is $8, which is a decrease of -4.48% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago · seekingalpha.com
Treace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call TranscriptTreace Medical Concepts, Inc. (NASDAQ:TMCI ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations, Gilmartin Group John Treace - Chi...
